Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer - Top-Institutions - MDSpire

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • By

  • Hongxia Wang

  • Yijie Li

  • Zhifen Yang

  • Jinxiu Wang

  • Kaiyun Qin

  • Yu Yu

  • Na Wang

  • Jingde Jia

  • Wenhong Zhao

  • Fenghua Zhang

  • Mario M. Leitao

  • Ran Meng

  • Yueping Liu

  • Yan Ding

  • Zhengmao Zhang

  • June 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Center
    National Cancer Center

    Tokyo, Japan

    Key Differentiators

    • Surgical Oncology

  • #2

    Fourth Hospital of Hebei Medical University
    Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei

    Key Differentiators

    • Surgical Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Surgical Oncology

  • #4

    Washington University School of Medicine in St. Louis
    Washington University School of Medicine in St. Louis

    St. Louis, Missouri

    Key Differentiators

    • Surgical Oncology

Original Source(s)

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • by Hongxia Wang, Yijie Li, Zhifen Yang, Jinxiu Wang, Kaiyun Qin, Yu Yu, Na Wang, Jingde Jia, Wenhong Zhao, Fenghua Zhang, Mario M. Leitao, Ran Meng, Yueping Liu, Yan Ding, Zhengmao Zhang

  • June 15, 2026

Related Content

Glioma management and outcome in low-middle-income countries: a systematic review

I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets